Miriam Melis, Ph.D. - Publications

Affiliations: 
2011- Dept. Biomedical Sciences University of Cagliari, Italy 
Area:
Neuropsychopharmacology
Website:
http://people.unica.it/miriammelis/

78 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sagheddu C, Traccis F, Serra V, Congiu M, Frau R, Cheer JF, Melis M. Mesolimbic dopamine dysregulation as a signature of information processing deficits imposed by prenatal THC exposure. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 105: 110128. PMID 33031862 DOI: 10.1016/j.pnpbp.2020.110128  1
2020 Medrano MC, Hurel I, Mesguich E, Redon B, Stevens C, Georges F, Melis M, Marsicano G, Chaouloff F. Exercise craving potentiates excitatory inputs to ventral tegmental area dopaminergic neurons. Addiction Biology. e12967. PMID 33021007 DOI: 10.1111/adb.12967  1
2020 Traccis F, Frau R, Melis M. Gender Differences in the Outcome of Offspring Prenatally Exposed to Drugs of Abuse. Frontiers in Behavioral Neuroscience. 14: 72. PMID 32581736 DOI: 10.3389/fnbeh.2020.00072  1
2019 Frau R, Miczán V, Traccis F, Aroni S, Pongor CI, Saba P, Serra V, Sagheddu C, Fanni S, Congiu M, Devoto P, Cheer JF, Katona I, Melis M. Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone. Nature Neuroscience. PMID 31611707 DOI: 10.1038/s41593-019-0512-2  1
2019 Cadoni C, De Felice M, Corongiu S, Dessì C, Espa E, Melis M, Fenu S. Role of genetic background in the effects of adolescent nicotine exposure on mesolimbic dopamine transmission. Addiction Biology. e12803. PMID 31342609 DOI: 10.1111/adb.12803  1
2019 Frau R, Fanni S, Serra V, Simola N, Godar S, Traccis F, Devoto P, Bortolato M, Melis M. Dysfunctional mesocortical dopamine circuit at pre-adolescence is associated to aggressive behavior in MAO-A hypomorphic mice exposed to early life stress. Neuropharmacology. PMID 30738037 DOI: 10.1016/j.neuropharm.2019.01.032  1
2019 Godar SC, Mosher LJ, Scheggi S, Devoto P, Moench KM, Strathman HJ, Jones CM, Frau R, Melis M, Gambarana C, Wilkinson B, DeMontis MG, Fowler SC, Coba MP, Wellman CL, et al. Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT receptor activation. Neuropharmacology. PMID 30716416 DOI: 10.1016/j.neuropharm.2019.01.028  1
2018 De Felice M, Melis M, Aroni S, Muntoni AL, Fanni S, Frau R, Devoto P, Pistis M. The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. Cns Neuroscience & Therapeutics. PMID 30461214 DOI: 10.1111/cns.13087  1
2018 Secci ME, Mascia P, Sagheddu C, Beggiato S, Melis M, Borelli AC, Tomasini MC, Panlilio LV, Schindler CW, Tanda G, Ferré S, Bradberry CW, Ferraro L, Pistis M, Goldberg SR, et al. Astrocytic Mechanisms Involving Kynurenic Acid Control Δ-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas. Molecular Neurobiology. PMID 30151725 DOI: 10.1007/s12035-018-1319-y  1
2018 Porcu A, Melis M, Turecek R, Ullrich C, Mocci I, Bettler B, Gessa GL, Castelli MP. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gαi/o protein inhibitor. Neuropharmacology. 133: 107-120. PMID 29407764 DOI: 10.1016/j.neuropharm.2018.01.024  1
2017 Sørensen AT, Ledri M, Melis M, Nikitidou Ledri L, Andersson M, Kokaia M. Altered Chloride Homeostasis Decreases the Action Potential Threshold and Increases Hyperexcitability in Hippocampal Neurons. Eneuro. 4. PMID 29379872 DOI: 10.1523/ENEURO.0172-17.2017  1
2017 Diana M, Raij T, Melis M, Nummenmaa A, Leggio L, Bonci A. Rehabilitating the addicted brain with transcranial magnetic stimulation. Nature Reviews. Neuroscience. PMID 28951609 DOI: 10.1038/nrn.2017.113  1
2017 Puligheddu M, Melis M, Pillolla G, Milioli G, Parrino L, Terzano GM, Aroni S, Sagheddu C, Marrosu F, Pistis M, Muntoni AL. Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy. Epilepsia. PMID 28766701 DOI: 10.1111/epi.13863  1
2017 Melis M, Frau R, Kalivas PW, Spencer S, Chioma V, Zamberletti E, Rubino T, Parolaro D. New vistas on cannabis use disorder. Neuropharmacology. PMID 28373077 DOI: 10.1016/j.neuropharm.2017.03.033  1
2016 Scheggi S, Melis M, De Felice M, Aroni S, Muntoni AL, Pelliccia T, Gambarana C, De Montis MG, Pistis M. PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors. Neuropharmacology. 110: 251-259. PMID 27457507 DOI: 10.1016/j.neuropharm.2016.07.024  1
2016 Fattore L, Melis M. Editorial: Exploring Gender and Sex Differences in Behavioral Dyscontrol: From Drug Addiction to Impulse Control Disorders. Frontiers in Psychiatry. 7: 19. PMID 26941657 DOI: 10.3389/fpsyt.2016.00019  1
2016 Fattore L, Melis M. Sex differences in impulsive and compulsive behaviors: a focus on drug addiction. Addiction Biology. PMID 26935237 DOI: 10.1111/adb.12381  1
2016 Luchicchi A, Lecca S, Melis M, De Felice M, Cadeddu F, Frau R, Muntoni AL, Fadda P, Devoto P, Pistis M. Maternal immune activation disrupts dopamine system in the offspring. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26819283 DOI: 10.1093/ijnp/pyw007  1
2016 Scherma M, Muntoni AL, Melis M, Fattore L, Fadda P, Fratta W, Pistis M. Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives. Psychopharmacology. PMID 26728894 DOI: 10.1007/s00213-015-4196-3  1
2015 Sagheddu C, Muntoni AL, Pistis M, Melis M. Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function. International Review of Neurobiology. 125: 257-302. PMID 26638769 DOI: 10.1016/bs.irn.2015.10.004  1
2015 De Luca MA, Bimpisidis Z, Melis M, Marti M, Caboni P, Valentini V, Margiani G, Pintori N, Polis I, Marsicano G, Parsons LH, Di Chiara G. Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid. Neuropharmacology. 99: 705-714. PMID 26327678 DOI: 10.1016/j.neuropharm.2015.08.041  1
2015 Sanna F, Contini A, Melis MR, Argiolas A. Role of dopamine D4 receptors in copulatory behavior: Studies with selective D4 agonists and antagonists in male rats. Pharmacology, Biochemistry, and Behavior. 137: 110-8. PMID 26287845 DOI: 10.1016/j.pbb.2015.08.012  1
2015 Sagheddu C, Aroni S, De Felice M, Lecca S, Luchicchi A, Melis M, Muntoni AL, Romano R, Palazzo E, Guida F, Maione S, Pistis M. Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain. Neuropharmacology. 97: 383-93. PMID 26113399 DOI: 10.1016/j.neuropharm.2015.06.003  1
2015 Sagheddu C, Melis M. Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system. Cns & Neurological Disorders Drug Targets. 14: 502-17. PMID 25714966  1
2015 Dudok B, Barna L, Ledri M, Szabó SI, Szabadits E, Pintér B, Woodhams SG, Henstridge CM, Balla GY, Nyilas R, Varga C, Lee SH, Matolcsi M, Cervenak J, Kacskovics I, ... ... Melis M, et al. Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nature Neuroscience. 18: 75-86. PMID 25485758 DOI: 10.1038/nn.3892  1
2015 Rubino T, Prini P, Piscitelli F, Zamberletti E, Trusel M, Melis M, Sagheddu C, Ligresti A, Tonini R, Di Marzo V, Parolaro D. Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex. Neurobiology of Disease. 73: 60-9. PMID 25281318 DOI: 10.1016/j.nbd.2014.09.015  1
2015 Melis M, Carboni E, Caboni P, Acquas E. Key role of salsolinol in ethanol actions on dopamine neuronal activity of the posterior ventral tegmental area. Addiction Biology. 20: 182-93. PMID 24103023 DOI: 10.1111/adb.12097  1
2015 Georges F, Melis M. Cannabinoid-dopamine interactions: Modulation of midbrain DA neurons by endocannabinoids Cannabinoid Modulation of Emotion, Memory, and Motivation. 443-470. DOI: 10.1007/978-1-4939-2294-9_17  1
2014 Melis M, Sagheddu C, De Felice M, Casti A, Madeddu C, Spiga S, Muntoni AL, Mackie K, Marsicano G, Colombo G, Castelli MP, Pistis M. Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 12716-24. PMID 25232109 DOI: 10.1523/JNEUROSCI.1844-14.2014  1
2014 Fattore L, Melis M, Fadda P, Fratta W. Sex differences in addictive disorders. Frontiers in Neuroendocrinology. 35: 272-84. PMID 24769267 DOI: 10.1016/j.yfrne.2014.04.003  1
2014 Melis M, Greco B, Tonini R. Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction. The European Journal of Neuroscience. 39: 1189-201. PMID 24712998 DOI: 10.1111/ejn.12501  1
2014 Melis M, Pistis M. Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: therapeutic perspectives. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 86: 42-9. PMID 24704146 DOI: 10.1016/j.phrs.2014.03.009  1
2014 Berglind F, Ledri M, Sørensen AT, Nikitidou L, Melis M, Bielefeld P, Kirik D, Deisseroth K, Andersson M, Kokaia M. Optogenetic inhibition of chemically induced hypersynchronized bursting in mice. Neurobiology of Disease. 65: 133-41. PMID 24491965 DOI: 10.1016/j.nbd.2014.01.015  1
2013 Melis M, De Felice M, Lecca S, Fattore L, Pistis M. Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats. Frontiers in Integrative Neuroscience. 7: 93. PMID 24416004 DOI: 10.3389/fnint.2013.00093  1
2013 Puligheddu M, Pillolla G, Melis M, Lecca S, Marrosu F, De Montis MG, Scheggi S, Carta G, Murru E, Aroni S, Muntoni AL, Pistis M. PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. Plos One. 8: e64541. PMID 23724059 DOI: 10.1371/journal.pone.0064541  1
2013 Melis M, Scheggi S, Carta G, Madeddu C, Lecca S, Luchicchi A, Cadeddu F, Frau R, Fattore L, Fadda P, Ennas MG, Castelli MP, Fratta W, Schilstrom B, Banni S, et al. PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 6203-11. PMID 23554501 DOI: 10.1523/JNEUROSCI.4647-12.2013  1
2013 Melis M, Carta G, Pistis M, Banni S. Physiological role of peroxisome proliferator-activated receptors type α on dopamine systems. Cns & Neurological Disorders Drug Targets. 12: 70-7. PMID 23394525 DOI: 10.2174/1871527311312010012  1
2012 Melis M, Pistis M. Hub and switches: endocannabinoid signalling in midbrain dopamine neurons. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 367: 3276-85. PMID 23108546 DOI: 10.1098/rstb.2011.0383  1
2012 Bortolato M, Godar SC, Melis M, Soggiu A, Roncada P, Casu A, Flore G, Chen K, Frau R, Urbani A, Castelli MP, Devoto P, Shih JC. NMDARs mediate the role of monoamine oxidase A in pathological aggression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 8574-82. PMID 22723698 DOI: 10.1523/JNEUROSCI.0225-12.2012  1
2012 Melis M, Muntoni AL, Pistis M. Endocannabinoids and the processing of value-related signals. Frontiers in Pharmacology. 3: 7. PMID 22347186 DOI: 10.3389/fphar.2012.00007  1
2012 Lecca S, Melis M, Luchicchi A, Muntoni AL, Pistis M. Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1164-76. PMID 22169942 DOI: 10.1038/npp.2011.302  1
2011 Lecca S, Melis M, Luchicchi A, Ennas MG, Castelli MP, Muntoni AL, Pistis M. Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 589-602. PMID 21048703 DOI: 10.1038/npp.2010.190  1
2010 Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M. Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors. Biological Psychiatry. 68: 256-64. PMID 20570248 DOI: 10.1016/j.biopsych.2010.04.016  1
2010 Fattore L, Melis M, Fadda P, Pistis M, Fratta W. The endocannabinoid system and nondrug rewarding behaviours. Experimental Neurology. 224: 23-36. PMID 20353776 DOI: 10.1016/j.expneurol.2010.03.020  1
2010 Pistis M, Melis M. From surface to nuclear receptors: the endocannabinoid family extends its assets. Current Medicinal Chemistry. 17: 1450-67. PMID 20166922 DOI: 10.2174/092986710790980014  1
2009 Melis M, Diana M, Enrico P, Marinelli M, Brodie MS. Ethanol and acetaldehyde action on central dopamine systems: mechanisms, modulation, and relationship to stress. Alcohol (Fayetteville, N.Y.). 43: 531-9. PMID 19913196 DOI: 10.1016/j.alcohol.2009.05.004  1
2009 Wanat MJ, Sparta DR, Hopf FW, Bowers MS, Melis M, Bonci A. Strain specific synaptic modifications on ventral tegmental area dopamine neurons after ethanol exposure. Biological Psychiatry. 65: 646-53. PMID 19118821 DOI: 10.1016/j.biopsych.2008.10.042  1
2009 Melis M, Pillolla G, Perra S, Colombo G, Muntoni AL, Pistis M. Electrophysiological properties of dopamine neurons in the ventral tegmental area of Sardinian alcohol-preferring rats. Psychopharmacology. 201: 471-81. PMID 18777018 DOI: 10.1007/s00213-008-1309-2  1
2008 Melis M, Pillolla G, Luchicchi A, Muntoni AL, Yasar S, Goldberg SR, Pistis M. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13985-94. PMID 19091987 DOI: 10.1523/JNEUROSCI.3221-08.2008  1
2008 Diana M, Peana AT, Sirca D, Lintas A, Melis M, Enrico P. Crucial role of acetaldehyde in alcohol activation of the mesolimbic dopamine system. Annals of the New York Academy of Sciences. 1139: 307-17. PMID 18991876 DOI: 10.1196/annals.1432.009  1
2007 Melis M, Pistis M. Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? Current Neuropharmacology. 5: 268-77. PMID 19305743 DOI: 10.2174/157015907782793612  1
2007 Melis M, Enrico P, Peana AT, Diana M. Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system. The European Journal of Neuroscience. 26: 2824-33. PMID 18001279 DOI: 10.1111/j.1460-9568.2007.05887.x  1
2007 Sanna F, Bonatesta RR, Frongia B, Uda S, Banni S, Melis MP, Collu M, Madeddu C, Serpe R, Puddu S, Porcu G, Dessì S, Batetta B. Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects. Journal of Vascular Research. 44: 253-63. PMID 17361089 DOI: 10.1159/000100903  1
2007 Pillolla G, Melis M, Perra S, Muntoni AL, Gessa GL, Pistis M. Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo. Psychopharmacology. 191: 843-53. PMID 17334799 DOI: 10.1007/s00213-007-0733-z  1
2006 Melis M, Pillolla G, Bisogno T, Minassi A, Petrosino S, Perra S, Muntoni AL, Lutz B, Gessa GL, Marsicano G, Di Marzo V, Pistis M. Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiology of Disease. 24: 15-27. PMID 16762556 DOI: 10.1016/j.nbd.2006.04.010  1
2006 Muntoni AL, Pillolla G, Melis M, Perra S, Gessa GL, Pistis M. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. The European Journal of Neuroscience. 23: 2385-94. PMID 16706846 DOI: 10.1111/j.1460-9568.2006.04759.x  1
2005 Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL, Pistis M. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo. Psychopharmacology. 183: 368-77. PMID 16228194 DOI: 10.1007/s00213-005-0195-0  1
2005 Melis M, Spiga S, Diana M. The dopamine hypothesis of drug addiction: hypodopaminergic state. International Review of Neurobiology. 63: 101-54. PMID 15797467 DOI: 10.1016/S0074-7742(05)63005-X  1
2005 Pistis M, Muntoni AL, Pillolla G, Perra S, Cignarella G, Melis M, Gessa GL. Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects. Neuroscience. 131: 465-74. PMID 15708487 DOI: 10.1016/j.neuroscience.2004.11.021  1
2004 Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, Di Marzo V, Gessa GL, Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10707-15. PMID 15564588 DOI: 10.1523/JNEUROSCI.3502-04.2004  1
2004 Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biological Psychiatry. 56: 86-94. PMID 15231440 DOI: 10.1016/j.biopsych.2004.05.006  1
2004 Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 53-62. PMID 14715937 DOI: 10.1523/JNEUROSCI.4503-03.2004  1
2004 Pistis M, Perra S, Pillolla G, Melis M, Gessa GL, Muntoni AL. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology. 46: 115-25. PMID 14654103 DOI: 10.1016/j.neuropharm.2003.08.003  1
2002 Melis M, Camarini R, Ungless MA, Bonci A. Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 2074-82. PMID 11896147  1
2001 Pistis M, Porcu G, Melis M, Diana M, Gessa GL. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation. The European Journal of Neuroscience. 14: 96-102. PMID 11488953 DOI: 10.1046/j.0953-816X.2001.01612.x  1
2000 Melis M, Gessa GL, Diana M. Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 24: 993-1006. PMID 11041539 DOI: 10.1016/S0278-5846(00)00119-6  1
2000 Fattore L, Melis M, Diana M, Fratta W, Gessa G. The cyclo-oxygenase inhibitor nimesulide induces conditioned place preference in rats. European Journal of Pharmacology. 406: 75-7. PMID 11011036 DOI: 10.1016/S0014-2999(00)00665-8  1
2000 Gessa GL, Devoto P, Diana M, Flore G, Melis M, Pistis M. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 642-9. PMID 10788763 DOI: 10.1016/S0893-133X(00)00087-7  1
2000 Melis M, Diana M, Gessa GL. Cyclo-oxygenase-inhibitors increase morphine effects on mesolimbic dopamine neurons. European Journal of Pharmacology. 387: R1-3. PMID 10633170 DOI: 10.1016/S0014-2999(99)00799-2  1
1999 Diana M, Muntoni AL, Pistis M, Melis M, Gessa GL. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. The European Journal of Neuroscience. 11: 1037-41. PMID 10103095 DOI: 10.1046/j.1460-9568.1999.00488.x  1
1999 Melis M, Diana M, Gessa GL. Clozapine potently stimulates mesocortical dopamine neurons. European Journal of Pharmacology. 366: R11-3. PMID 10082220 DOI: 10.1016/S0014-2999(98)00934-0  1
1998 Melis M, Gessa GL, Diana M. Clozapine does activate nigrostriatal dopamine neurons in unanesthetized rats. European Journal of Pharmacology. 363: 135-8. PMID 9881580 DOI: 10.1016/S0014-2999(98)00822-X  1
1998 Diana M, Melis M, Gessa GL. Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids. The European Journal of Neuroscience. 10: 2825-30. PMID 9758152 DOI: 10.1111/j.1460-9568.1998.00292.x  1
1998 Diana M, Melis M, Muntoni AL, Gessa GL. Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proceedings of the National Academy of Sciences of the United States of America. 95: 10269-73. PMID 9707636 DOI: 10.1073/pnas.95.17.10269  1
1998 Gessa GL, Melis M, Muntoni AL, Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. European Journal of Pharmacology. 341: 39-44. PMID 9489854 DOI: 10.1016/S0014-2999(97)01442-8  1
1998 Melis M, Mereu G, Lilliu V, Quartu M, Diana M, Gessa GL. Haloperidol does not produce dopamine cell depolarization-block in paralyzed, unanesthetized rats. Brain Research. 783: 127-32. PMID 9479061 DOI: 10.1016/S0006-8993(97)01316-4  1
1997 Castelli MP, Melis M, Mameli M, Fadda P, Diaz G, Gessa GL. Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain. Brain Research. Molecular Brain Research. 45: 149-53. PMID 9105683 DOI: 10.1016/S0169-328X(96)00305-1  1
1984 Gessa GL, Fratta W, Melis M, Bertolini A, Ferrari W. Hypothalamic ACTH and MSH levels increase in morphine tolerance and decrease after morphine withdrawal. European Journal of Pharmacology. 95: 143-4. PMID 6321202 DOI: 10.1016/0014-2999(83)90280-7  0.48
Show low-probability matches.